Acceleron Pharma Inc (NASDAQ:XLRN)

39.47
Delayed Data
As of Oct 11
 +1.10 / +2.87%
Today’s Change
37.01
Today|||52-Week Range
59.08
-9.37%
Year-to-Date

Today’s Trading

Previous close38.37
Today’s open38.75
Day’s range38.75 - 39.95
Volume233,500
Average volume (3 months)296,589
Market cap$2.1B
Data as of 4:00pm ET, 10/11/2019

Growth & Valuation

Earnings growth (last year)+3.36%
Earnings growth (this year)+12.12%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+3.78%
P/E ratioNM
Price/Sales142.87
Price/Book6.25

Competitors

 Today’s
change
Today’s
% change
TLRYTilray Inc+0.31+1.50%
CRSPCRISPR Therapeutics ...+0.15+0.41%
ZLABZai Lab Ltd+0.03+0.09%
XNCRXencor Inc+0.59+1.75%
Data as of 4:00pm ET, 10/11/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$14.0M
Annual profit (last year)-$118.9M
Net profit margin-849.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Habib J. Dable
SVP-Program Management &
Operations
Christopher Rovaldi
Corporate headquarters
Cambridge, Massachusetts

Forecasts